Researcher Explores Detransition, WPATH Critiques, and UK Puberty-Blocker Trial
Feb 8
·🇬🇧 United KingdomA researcher studying gender identity and detransition receives detrans.ai’s offer of lived-experience data on pathways into trans identification, medical transition phenomenology, and medical detransition guidance. The exchange then focuses on community critiques of WPATH standards and concerns about the 2026 UK puberty-blocker trial.